After completing this course you’ll be able to:
| 1. | Describe the continuum of drug use according to Figure 1. |
| 2. | Describe a users expectations when drinking alcohol. |
| 3. | State the most effective way for mental health professionals to learn about drugs. |
| 4. | Describe the percent of Americans who have used an illicit drug. |
| 5. | List and define dependence symptoms (Table 3). |
| 6. | List abuse symptoms (Table 4). |
| 7. | State the most prevalent illicit drug across nations. |
| 8. | State which ethnic group has a higher percentage of drug use |
| 9. | State which groups received the diagnosis of abuse and dependence most often. |
| 10. | State the age at which most drug use begins and why this is the best predictor of problems. |
| 11. | Discuss the effects of comorbidities and the prognosis. |
| 12. | Discuss drug problems among those with problem gambling, eating disorders and attention deficit disorder. |
| 13. | Discuss the borderline personality disorder and substance abuse. |
| 14. | Discuss suicide attempts among drug dependent individuals. |
| 15. | Discuss substance abuse and genetics. |
| 16. | List several factors that improve treatment. |
| 17. | Discuss note taking when conducting an assessment. |
| 18. | Describe the Timeline Follow-Back. |
| 19. | Describe the contemplation ladder. |
| 20. | Discuss the research of Jungerman, et al., 2007 regarding duration of treatment. |
| 21. | List safer methods of drug administration when compared to intravenous administration. |
| 22. | List several events that impact a drug user’s trajectory. |
| 23. | Describe motivational interviewing. |
| 24. | Define self-efficacy. |
| 25. | Describe the decisional balance. |
| 26. | Define challenging. |
| 27. | Define prolapsed, relapse, and lapse. |
| 28. | Describe the interpersonal and intrapersonal categories. |
| 29. | Define alexthymia. |
| 30. | Describe the 12-step facilitation therapy (TSF). |
| 31. | Describe Vipassana meditation. |
| 32. | List several drugs approved for treatment for drug-related and alcohol disorders. |